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Healthcare-associated bloodstream infections in
critically ill patients: descriptive cross-sectional
database study evaluating concordance with
clinical site isolates
Nick Culshaw1, Guy Glover1, Craig Whiteley1, Katie Rowland1, Duncan Wyncoll1, Andrew Jones1
and Manu Shankar-Hari1,2*
Abstract
Background: Healthcare-associated bloodstream infections are related to both increased antibiotic use and risk of
adverse outcomes. An in-depth understanding of their epidemiology is essential to reduce occurrence and to
improve outcomes by targeted prevention strategies. The objectives of the study were to determine the epidemiology,
source and concordance of healthcare-associated bloodstream infections with clinical site isolates.
Methods: We conducted a descriptive cross-sectional study in critically ill adults admitted to a tertiary semi-closed
intensive care unit in England to determine the epidemiology, source and concordance of healthcare-associated
bloodstream infections with clinical site isolates. All nosocomial positive blood cultures over a 4-year study period
were identified. Pathogens detected and concordances with clinical site are reported as proportions.
Results: Contaminant pathogens accounted for half of the isolates. The most common non-contaminant pathogens
cultured were Pseudomonas spp. (8.0%), Enterococcus spp. (7.3%) and Escherichia coli (5.6%). Central venous catheter-linked
bloodstream infections represent only 6.0% of the positive blood cultures. Excluding contaminants and central venous
line infections, in only 39.5% of the bloodstream infections could a concordant clinical site source be identified, the
respiratory and urinary tracts being the most common.
Conclusions: Clinical practice should focus on a) improving blood culture techniques to reduce detection of
contaminant pathogens and b) ensuring paired clinical site cultures are performed alongside all blood cultures to
better understand the epidemiology and potential implications of primary and secondary discordant health-care
associated bloodstream infections.
Keywords: Bacteremia; Intensive care units; Nosocomial infections
Background
Healthcare-associated infections (HCAIs) [1] are common
in patients managed in a critical care setting (ICU) [2-6].
HCAIs are often associated with indwelling devices and/
or breach of natural barrier defence mechanisms and thus
are potentially preventable with modifications in practice
[7-12]. HCAI bloodstream infections in an ICU setting
(ICU-BSIs) refer to the detection of pathogenic organisms
in blood culture 48 h or more following ICU admission
[1,5]. Similar to other HCAIs in an ICU setting, ICU-BSIs
are common and patients who develop ICU-BSIs are at
higher risk of adverse outcomes [2-5,13,14].
ICU-BSI can either occur secondary to the dissemin-
ation of pathogens from a primary focus of infection at a
clinical site into the bloodstream, or can be primary
where the source of infection is unclear. The common
clinical site foci for secondary ICU-BSI are the respiratory,
gastrointestinal and urinary tracts [3-6,15-17]. Although,
several studies have examined the epidemiology and the
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prognostic utility of ICU-BSI, a useful addition to this lit-
erature would be the assessment of concordance between
the pathogens isolated from ICU-BSI and those isolated
from clinical site sampling that define HCAI. To address
this question, we conducted a descriptive study of positive
blood cultures identified in adult critically ill patients 48 h
or more following admission to a single centre tertiary
ICU in England over a 4-year period. The study objectives
were to describe the epidemiology of pathogens identified
in ICU-BSI and to determine the proportions of secondary
ICU-BSI by identifying the most likely clinical source of
ICU-BSI and the proportions of primary ICU-BSI where
no corresponding clinical site could be identified.
Methods
Setting
Guy's and St. Thomas' NHS Foundation Trust (GSTT;
London, England) is a 1,150-bed teaching hospital with a
semi-closed, mixed medical and surgical ICU (approxi-
mately 70% medical and 30% surgical admissions). The
infection prevention and control practices in our ICU
areas include the Department of Health ventilator-associated
pneumonia (VAP) prevention bundle [18], antibiotic guide-
lines with a course limited to 5 days [19], screening for
MRSA and gentamicin-resistant Gram-negative bacilli
on admission, universal chlorhexidine daily bathing (since
2007 and throughout the entire duration of the study) and
limiting the duration of peripheral lines to 3 days. The
ICU does not use selective digestive tract decontamin-
ation, but chlorhexidine oral gel is used as part of the VAP
prevention bundle. Blood cultures are not taken from
indwelling vascular access catheters. Precautions against
catheter-linked bloodstream infections (CLBSIs) included
the use of antimicrobial-impregnated central venous cath-
eters, chlorhexidine-impregnated dressing sponges and a
daily checklist that incorporated a reminder to review the
need to remove or change the central catheter. Clinical
care of the patients and the initial decision to send micro-
biological investigations was at the discretion of the treat-
ing physicians.
Study population and blood culture database
Between December 2009 and November 2013, consecu-
tive ICU admissions with an ICU length of stay greater
than 48 h and who had at least one positive blood culture
result greater than 48 h post-ICU admission were detailed
prospectively in a quality improvement database (Access,
Microsoft, New York, USA). Since inception, the database
was updated weekly directly from the institution's central
microbiological system. The hospital microbiology reports
use a combination of colony morphology, Gram-staining
and API® identification system (Biomérieux, Durham, USA) to
identity and quantify (semi-quantitative) the microorganism
identified in blood culture and clinical site samples. All
positive blood cultures were then reviewed by one of four
ICU physicians (DW, AJ, GG or MSH) with reference to
electronic clinical records, imaging and other laboratory
and microbiological data to determine the source of in-
fection. Where there was uncertainty, a consensus view
was obtained with review by two or more of the par-
ticipating physicians. The data collection and analysis
for this study were part of an ongoing GSTT hospital-
approved clinical quality improvement and audit process,
for which informed consent was waived for collection and
reporting of anonymised data.
Definitions
CLBSIs were identified from blood culture results and
microbiological data as the database was updated. The
CLBSI group includes both catheter-associated blood-
stream infection (CABSI) and catheter-related blood-
stream infection (CRBSI) defined using the accepted
standard definitions [1,11]. The non-CLBSI results were
then categorised according to the species cultured. Results
yielding contaminant species only were classified as ‘con-
taminants’ and results yielding potentially pathogenic spe-
cies were classified as ICU-BSI. Microbiology culture
results for clinical site samples taken within 48 h of the
positive blood culture were then analysed in an attempt to
identify primary sites of infection. When no clinical site
culture results were positive, then the blood culture result
was defined as a primary ICU-BSI. Blood culture results
that did have positive clinical site culture results were clas-
sified as secondary ICU-BSI. Detection of pathogens with
similar antibiogram in ICU-BSI and in clinical site samples
taken within 48 h of the blood culture defined a concord-
ant secondary ICU-BSI [1]. If a pathogen was present in
blood culture and there was a clinical site isolate which
did not satisfy the definition of concordance described
above, then the results were defined as discordant second-
ary ICU-BSI. In line with accepted definitions, the follow-
ing blood culture and clinical site isolates were classified
as contaminants unless there were two or more concord-
ant culture positive results and/or clinical site of infection
identified by a treating physician: diphtheroids (Coryne-
bacterium spp.), Bacillus (not Bacillus anthracis) spp.,
Propionibacterium spp. and coagulase-negative Staphylo-
cocci (CoNS).
Statistics
The clinical details of the study cohort are presented as
mean and standard deviation for continuous variables and
as median and interquartile range for categorical variables.
The microbiological results are presented as number and
proportions with a denominator for calculating proportion
presented in the tables.
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Results
Study cohort
The case definition used identified 326 patients with one
or more positive blood cultures. The mean (SD) age of
the cohort was 60.8 (16.4) years and 65.2% were male.
The mean (SD) APACHE II score on admission was 19.2
(6.3) and the median (interquartile range (IQR)) admission
day total sequential organ failure assessment (t-SOFA)
score was 6 [4,9]. The ICU and hospital mortality of
the study cohort was 31.5% and 38.3%, respectively.
The median (IQR) ICU LOS was 14 [6,20] (Table 1).
The respiratory-, cardiovascular- and renal-specific SOFA
scores, organ support provided and other characteristics
of patients on the day of positive blood culture are shown
in Table 2.
Blood culture results
Over the 48-month study period 507 positive blood cul-
ture results were recorded, with 537 individual isolates
identified from these positive results. Of the blood cul-
tures, 5.7% (n =29) contained more than one isolate with
28 identifying two isolates and one blood culture identi-
fying three isolates (Table 2). Of the organisms detected,
94.4% (n =507) were bacterial. Gram-positive bacteria
(GPB) were the predominant organism isolated (62.0%
(n =333)) followed by Gram-negative bacteria (GNB)
(32.4% (n =174)) and fungi (5.6% (n =30)). Contaminant
species were the sole organisms cultured in 51.3%
(260/507) of the positive blood cultures (Figure 1).
CLBSI
CLBSI accounted for 6.0% (32/537) of all the positive
blood culture isolates identified by our case definition
and 12.2% (32/262) of all the ICU-BSIs when contaminant
pathogens not meeting CLBSI definitions were excluded.
During the 48-month study period, there were 5,982 pa-
tients with a central venous catheter (CVC) resulting in a
total of 36,838 CVC days. The 3-month rolling average
mean CRBSI rate was 0.66/1,000 CVC days and CLBSI
rate was 1.19/1,000 CVC days. GPB and GNB accounted
for most of the CLBSIs (Table 3). The majority of CLBSIs
related to internal jugular lines (63%) compared to 19%
femoral, 9% subclavian and others (peripherally inserted
central catheters). The median (IQR) ICU length of stay
before a CLBSI occurred was 8 (3 to 14) days, and the me-
dian duration of insertion for CLBSI lines were internal
Table 1 Study population
Parameter Results Missing
values n(%)
Age (years) 60.0 (15.4) 0
Sex (female:male) 110:216 0
Medical:surgical 286:40 1 (0.2)
Source of admission: 1 (0.2)
Ward n(%) 91 (27.2)
Other hospital n(%) 94 (28.4)
Emergency department n(%) 51 (15.4)
Theatre 40 (12.1)
Other n(%) 50 (15.3)
APACHE II score (admission day) 18.8 (5.5) 2 (0.006)
Total SOFA score (admission day) 7 (4 to 10) 1 (0.2)
Hospital LOS prior to ICU admission (days) 1 (0 to 6) 3 (0.6)
Critical care LOS prior to first blood
culture positive culture positive (days)
9 (5 to 16) 20 (6.1)
Critical Care LOS (days) 24 (13 to 40) 28 (5.4)
Ventilator days 23 (11 to 39) 14 (4.3)
ICU mortality/hospital mortality (%) 34.7/39.8 1 (0.2)
Table 2 Characteristics of patients on the day of positive
blood culture
Parameter Results Missing values n(%)
Number of lines in situ 0
n =1 179 (54.9)
n =2 121 (36.6)
n =3 23 (7.0)
n =4 3 (0.9)
Respiratory SOFA score 0
0 8 (2.5)
1 27 (8.4)
2 116 (36.2)
3 137 (42.5)
4 38 (11.8)
Mechanical ventilation 287 (88) 0
Airway 0
Endotracheal tube 169 (51.8)
Tracheostomy 128 (39.2)
Mask 29 (8.9)
Renal SOFA score
0 105 (33.0)
1 41 (12.4)
2 31 (9.4)
3 45 (13.6)
4 104 (31.4)
Renal replacement therapy 136 (41.7) 0
CVS SOFA score
0 35 (10.7)
1 100 (30.2)
2 0
3 51 (15.4)
4 140 (42.3)
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jugular 132 (120 to 168) hours, femoral 98 (96 to 115)
hours and subclavian 670 (397 to 702) hours. Recognised
risk factors for CLBSI were present in many patients
(mechanical ventilation 74%, blood transfusion 54%, ste-
roids 23% and parenteral nutrition 21%).
Primary and secondary ICU-BSI
A total of 238 isolates, identified from 217 non-CLBSI,
non-contaminant blood cultures (with n =19 with two
and n =1 with three isolates) were compared with clinical
site cultures to identify primary and secondary ICU-BSI
(Table 3). Secondary ICU-BSIs were more common than
primary ICU-BSIs (n =165 (69.3%) and n =73 (30.7%),
respectively). The most common pathogens isolated in
primary ICU-BSI are detailed in Table 3.
Amongst the secondary ICU-BSIs, concordant second-
ary ICU-BSIs were more common than discordant sec-
ondary ICU-BSIs (94/165 (57.0%) and 71/165 (43.0%),
respectively). The most common clinical site of concord-
ant secondary ICU-BSI was the respiratory tract, and the
pathogens isolated most often were Pseudomonas spp.,
Escherichia coli and Staphylococcus aureus. Amongst the
discordant ICU-BSI, the most common clinical site was
again the respiratory tract. The most common pathogens
isolated in ICU-BSI with discordant clinical site isolate
were Klebsiella spp., Enterococcus faecium and E. coli
(Table 4).
Discussion
In an adult ICU setting, CLBSIs accounted for 6.0% of
all positive blood cultures and 12.2% of all ICU-BSIs
with a CRBSI rate of 0.66/1,000 catheter days, much lower
than the published literature. Fungaemia accounted for a
significant minority of positive blood cultures (5.6% of
all positive cultures and 11.5% of all ICU-BSIs). Amongst
ICU-BSIs, a discordant clinical site or no clinical site
could be identified in the majority (60.5%) of the positive
blood cultures. Secondary concordant ICU-BSIs were
more common than secondary discordant ICU-BSIs.
The respiratory tract was the most common site of in-
fection and GNB were the predominant isolates in the
ICU-BSIs identified.
Inability to identify a clinical site source (primary ICU-
BSI) and discordant secondary ICU-BSI in 60% of the
study population are key findings addressing the study
objective and could have several possible explanations.
Firstly, these isolates may not represent true ICU-BSIs
but detection of potentially pathogenic organisms colonis-
ing the skin site from where blood cultures were taken,
i.e. ‘contamination with potentially pathogenic organisms’.
Secondly, paired sampling of suspected clinical site and
Positive blood culture
[n=520 results]
Included for evaluation
[n=507 blood culture
results with 537
isolates]
Contaminant species
only [n=260 results
with 263 isolates]
ICU-BSI [n=221 results
with 238 isolates]
CLBSI [n=31 results with 32 isolates
including 6 contaminant species]
Primary [n=73] Secondary [n=165]
Concordant [n=94 isolates with
>= 1 concordant site[s]]
Discordant [n=71 isolates with
>=1 discordant site[s]]
13 excluded
Reasons for exclusion: 9 missing data; 3 duplicates and 1
not blood culture
Figure 1 Shows the flow diagram for blood culture results.
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blood culture was not mandated in our study, thus
falsely identifying primary ICU-BSI by not detecting a
corresponding clinical site infection. Thirdly, there were
occult sources of infection that were not identified or
suspected and therefore not cultured, potentially falsely
identifying either primary ICU-BSI or non-concordant
secondary ICU-BSI (if original blood culture had multiple
isolates). Finally, both primary ICU-BSI and secondary
non-concordant ICU-BSI (multiple isolates) may reflect
infection from a source that is not feasible to sample -
the most obvious being translocation from the gastro
intestinal (GI) tract as nearly 83% of all clinical isolates
could be detected first in microbiological sampling of
the GI tract [12].
The key design strength is the consistent temporal
review process with a limited number of experienced
reviewers working to agreed criteria with access to con-
temporaneous medical records. The study reports all posi-
tive blood cultures isolated in a large critical care service
with high compliance rates in HCAI prevention strategies
and antimicrobial use [19] thus providing a representative
sample from which inferences about practice interven-
tions could be made. Our results have similarities with the
report from another tertiary-level critical care unit in
London [21], giving it further validity. The study setting is
a large mixed medical and surgical ICU with high compli-
ance with infection prevention and control measures.
Our study has a number of limitations. It is a retrospect-
ive, descriptive database review of bacteraemia cases. Al-
though the blood culture practices were standardised,
neither the sampling method nor the paired clinical site
samples were mandated, thus potentially introducing bias
from clinical site samples processed due to ease. As a
descriptive study, we have not adjusted for potential
confounders. However, the aim was to report an updated
Table 3 Types and species of organisms isolated in all positive blood cultures, in CLBSI and in primary ICU-BSI
Organism isolated All isolates (n =537) CLBSI (n =32a) Primary ICU-BSI (n =73)
Gram-positive 333 (62.0) 10 (1.9) 20 (27.4)
Staphylococcus species (CoNS) 246 (45.8) 6 (1.1) -
Other contaminant species 26 (4.8) - -
Vancomycin-sensitive Enterococcus 31 (5.8) 2 (0.4) 12 (16.4)
Methicillin-sensitive S. aureus 13 (2.4) 1 (0.2) 2 (2.7)
Vancomycin-resistant Enterococcus 8 (1.5) 1 (0.2) 4 (5.5)
Streptococcus other species 4 (0.7) - 2 (2.7)
Methicillin-resistant S. aureus 1 (0.2) - -
Streptococcus pneumoniae 1 (0.2) - -
Unidentified probable contaminant 3 (0.6) - -
Gram-negative 174 (32.4) 13 (2.4) 45 (61.6)
Escherichia coli 32 (5.6) 1 (0.2) 7 (9.6)
Pseudomonas aeruginosa 43 (8.0) 6 (1.1) 6 (8.2)
Other 35(6.5)b 1 (0.2)c 13 (17.8)
Klebsiella species 27 (5.0) 4 (0.7) 10 (13.7)
Serratia species 18 (3.4) - 5 (6.8)
Enterobacter species 19 (3.5) 1 (0.2) 4 (5.5)
Fungi 30 (5.6) 9 (1.7) 8 (11.0)
Candida species 30 (5.6) 9 (1.7) 8 (11.0)
aDenominator for calculating proportions was the total number of positive blood culture isolates (n =537). bIncludes Proteus, Bacteroides, Citrobacter, Morganella
and Stenotrophomonas species. cProteus mirabilis.
Table 4 Attributed sources of secondary ICU acquired
bloodstream infections
Source of blood culture isolate Concordant
isolate n(%)
Discordant
isolates n(%)
Pulmonary (BAL or sputum) 50(53.2) 50(70.4)
Renal/urinary tract 22(23.4) 25(35.2)
Skin and soft tissue 8(8.5) 11(15.5)
Other (aortic valve graft, joint
aspirate, limb tissue)
8(8.5) 10(14.1)
Intra-abdominal (fluid or surgical
swab)
10(10.6) 6(8.5)
Surgical wound site 3(3.2) 5(7.0)
Note: Isolates have been attributed to multiple sources where concordant
cultures exist for more than one organ system within the 48-h window before
and after the blood culture was taken. Denominator for calculating proportions
were the total number of concordant isolates (n =94) and discordant isolates
(n =71). BAL, bronchoalveolar lavage.
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epidemiology of blood cultures from an ICU in England
and to explore the concept of concordance between ICU-
BSI and clinical site of nosocomial infections.
Along with detection of CoNS spp. as the commonest
contaminant, the most common pathogenic GPB isolates
in our study were S. aureus spp. and Enterococcus spp.,
which correspond to the published literature [4,16,21-26].
The most common pathogenic GNB isolates in our study
were E. coli, Klebsiella spp. and Pseudomonas aeruginosa
spp. which are similar to other ICU studies [4,16,21-26].
Primary ICU-BSI was observed in 31.6% of our cohort,
which is similar to the study by Stohl et al. [25] but higher
than some reports [22,27] and may be partially explained
by our study design, with paired cultures not mandated.
Nearly 11% of ICU-BSI isolates were fungi and most often
Candida species, which is similar to a large multicentre
study of nosocomial BSI from the United States [14]. In
primary ICU-BSI, 70% of isolates were enteric pathogens
implying either an occult GI source of infection or GI
translocation, which corresponds to published literature
on the role of GI tract in pathogenesis of nosocomial in-
fections [12,28]. Corona et al. in a single centre ICU sur-
veillance of blood cultures report that nearly 90% of
bacteraemia episodes satisfy the HCAI definitions [21].
The proportion of fungaemia in the study was 3%, in 45%
of patients with HCAI the source of infection was GI or
respiratory, and there was an excess of contaminant cul-
tures, which are comparable results to our study [22]. Fi-
nally, CLBSI rate in our study was 1.19/1,000 CVC days
and the CRBSI rate was 0.66/1,000 CVC days, both signifi-
cantly lower than the mean rates reported for adult ICUs
in England [11]. This is reflective of the multifaceted inter-
ventions in place in our ICU, which aims to optimise sterile
insertion technique and ongoing line care, whilst avoiding
femoral access and the prolonged dwell time of unneces-
sary lines.
More than 50% of positive blood cultures isolated were
contaminant species, which is often related to poor tech-
nique and results in inappropriate empiric antibiotic ther-
apy with its attendant challenges. Consequently, efforts to
reduce ‘contaminant rates’ in critically ill patients would
seem a worthwhile strategy. Contaminant rates in blood
culture are usually reported as between 0.6% and 10%
when the denominator used to calculate the rates is all
blood cultures sent to the lab. In our study, the high rate
of contaminants is artificially high as our denominator is
all positive blood cultures and not all blood cultures sent
to the lab. When applying the same definition as pub-
lished literature the contaminant rates seen in our ICU
was 2.3% (between July and September 2014, unpublished
data from local audit).
A number of strategies have been proposed to reduce
the contaminant rates, as well as to reduce true bacter-
aemias. A key intervention to reduce blood culture
contamination in ICU patients is the use of chlorhexi-
dine baths, which has been implemented in our ICU
before the study period as part of routine clinical care
[29-31]. Another potential intervention is selective oral
and/or digestive tract decontamination (SDD/SOD).
Aside from chlorhexidine for oral application as part of
the routine VAP bundle, SDD/SOD is not used in our
ICU. The challenges with SDD/SOD include (but are
not limited to) costs, potential for generating resist-
ance pathogens, inconsistent effect on mortality and
potential for altering the pathogen ecology of the ICU
where the intervention is implemented, and questions
remain regarding the ideal combination of drugs for this
intervention [20,32].
The primary ICU-BSI and discordant secondary ICU-BSI
represent either inadvertent sampling of clinically irrelevant
organisms (akin to contaminants) or yet-to-be-determined
secondary sources of infection; both have implications re-
garding antibiotic course duration and risk of recurrence.
Therefore, in the presence of primary or particularly dis-
cordant secondary ICU-BSI, the clinician should actively
consider investigations to exclude occult infections or re-
peat the microbiology surveillance for the most likely clin-
ical site. Thus further research is required to explore the
implications of isolating either a secondary discordant
ICU-BSI or a primary ICU-BSI where paired cultures of
potential sites have been sent, to answer the potential add-
itional morbidity and antibiotic use in this population.
This question is relevant as similar to culture positive and
culture negative sepsis [3], the outcomes might differ be-
tween concordant and discordant blood cultures depend-
ing on treatment variables.
Conclusions
Contaminant species are frequently isolated in blood
cultures performed in ICU patients, but rarely represent
true ICU-BSI thus should be a focus for future quality
improvement strategies. CLBSI and fungaemia represent
only a small proportion of ICU-BSI at our institution. In
concordant ICU-BSIs, respiratory and urinary tract infec-
tion were the most common sources. In trying to reduce
the burden of ICU-BSI, the focus should be on imple-
menting strategies to prevent respiratory and urinary tract
infections in ICU, alongside contaminant reduction.
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